P

Pfizer

Makes cancer drugs, vaccines and other medicines

Health Representative

Full-TimeUpdated on 10/22/2026
No salary listed
Junior
Bachelor's
George Town, Penang, Malaysia
RemoteRemote, field-based work; must live within the territory.
Sales & Account ManagementField Sales

About the job

Requirements
  • A Bachelor's degree is preferred, with a preference for a Pharmacy, Science, or Health background.
  • A minimum of 2 years of previous sales experience is an added advantage.
  • A history of promotional or sales success, territory management skills, effective communication skills, teamwork, leadership ability, and accountability.
  • A valid driver's license and a driving record compliant with company standards.
  • Pharmaceutical, biotech, sales, or relevant experience is preferred.
  • Experience with therapeutic areas and products associated with the role is preferred.
  • Knowledge of territory customers and markets, including prescribers, health care professionals, institutions, and organizations, is preferred.
  • A demonstrated track record of business acumen, problem solving, strategic thinking, data analytical skills, project management skills, planning, and prioritization is preferred.
  • The ability to engage, influence, and support customers throughout the sales process is preferred.
  • The ability to quickly learn and embrace new ways of working in a rapidly changing environment is preferred.
  • Strong organizational and analytical skills, and the ability to analyze and draw appropriate conclusions using sales data and call-reporting software or applications, are required; the candidate must also be able to learn and use new technology to deliver Pfizer information to market.
  • The candidate must live within the territory.
Responsibilities
  • Serve as the central contact connecting customers within assigned accounts to therapies, promoted medicines, and digital services that support patient care.
  • Use healthcare knowledge and understanding of the health and pharmaceutical industry, Pfizer, and its product portfolio to help customers achieve the solutions they need.
  • Plan and execute relationship strategies and build and maintain long-term business relationships with assigned territory customers.
  • Identify and prioritize business opportunities by understanding customers' business and strategic imperatives; develop and execute sales plans for channels and health care professionals.
  • Identify and implement virtual and in-person customer engagement strategies; develop and adapt business and territory call plans based on opportunities and insights.
  • Build rapport and relationships with customers across virtual and face-to-face settings, manage call objectives and key performance indicators, document appropriate next steps, use digital tools, and leverage analytics to develop insights and next-best-action plans.
  • Engage key customers compliantly and provide education that best meets health care professional and patient needs to grow business and product demand.
  • Deliver targeted messaging using approved materials to drive product demand, respond to customer priorities, and provide insights for the development of approved product messaging and resources.
  • Maintain market, product, and disease-state knowledge to conduct meaningful dialogue with stakeholders and add value when calling on providers.
  • Deploy Pfizer resources strategically to support health care professionals, including patient education and adherence resources; use virtual engagement platforms in line with customer preferences and compliance guidelines; integrate guidance from management and support functions and technical solutions into call planning; and collaborate with customer-facing colleagues.
  • Present contract terms where appropriate, answer on-label questions, and introduce customers to Pfizer Pro and relevant targeted content.
  • Collaborate compliantly with Medical, Market Access, Marketing, and other cross-functional colleagues to address customer inquiries and advance Pfizer objectives; connect customers with appropriate subject-matter experts.
  • Use calendaring tools, leadership goals, and personal insights to address customer priorities during calls, and share customer survey insights with leadership to improve the model.
  • Develop comprehensive territory and customer plans to achieve objectives.
  • Overcome obstacles to gain access to health care providers and customers who are difficult to reach.
  • Cultivate relationships with key opinion leaders and build lasting relationships with priority customers.
  • Assess target physicians' needs and address them with responsive approaches, targeted skills, and appropriate resources.
Desired Qualifications
  • Experience with therapeutic areas and products associated with the role.
  • Knowledge of territory customers and markets, including prescribers, health care professionals, institutions, and organizations.
  • A demonstrated track record of business acumen, problem solving, strategic thinking, data analytical skills, project management skills, planning, and prioritization.
  • The ability to engage, influence, and support customers throughout the sales process.
  • The ability to quickly learn and embrace new ways of working in a rapidly changing environment.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 21st, 2026
Pfizer announces layoffs at Rocky Mount and Sanford sites, but gives no numbers

Pfizer has announced layoffs at its Rocky Mount and Sanford facilities in North Carolina, as part of a push to improve efficiency. It told employees of the cuts on Tuesday but did not say how many jobs will go, when, or in which departments. Rocky Mount makes sterile injectables, while Sanford focuses on vaccines and advanced biologics, including gene therapies. "Headcount reductions are a part of this initiative," Pfizer said, adding that it will give affected staff support services. "If indeed this happens, it's going to affect those families," said David Farris, president and chief executive officer of the Rocky Mount Area Chamber of Commerce. The impact on local economies, he said, depends on the number laid off. As of Wednesday afternoon, no Worker Adjustment and Retraining Notification (WARN) notice had been filed with the state.

Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.